Loading...
Market
Outcome of the U.S. Senate HELP Committee's vote on June 18
5
Resolution / Starting Odds
Subpoena issued • 33%
Subpoena not issued • 33%
Vote postponed • 33%
Official announcement from the U.S. Senate HELP Committee
Story
U.S. Senate Panel to Vote on June 18 on Subpoena for Novo Nordisk Over Ozempic, Wegovy Prices
Jun 11, 2024, 03:00 PM
The U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee, chaired by Senator Bernie Sanders, announced it will vote on June 18 to decide whether to subpoena Doug Langa, President of Novo Nordisk Inc. This action is prompted by the significant price disparity for weight loss drugs Ozempic and Wegovy between the U.S. and other countries. Americans are charged $969 for Ozempic, while Germans pay only $59. The committee seeks an explanation for why these drugs cost up to 10 to 15 times more in the U.S. compared to other nations. Novo Nordisk has not yet provided a satisfactory response to these inquiries. The vote will take place later this month.
View original story
Similar markets
Contempt Approved • 33%
Contempt Denied • 33%
Vote Postponed • 34%
Resolution Passes • 33%
Resolution Fails • 33%
Vote Postponed • 34%
Passes • 33%
Fails • 33%
Postponed • 34%
Restored • 33%
Not Restored • 33%
No Vote Held • 33%
Passed Unanimously • 25%
Passed with Opposition • 25%
Rejected • 25%
Stalled or Delayed • 25%
Passed • 33%
Not Passed • 33%
Vote Delayed • 34%
Passes with majority • 33%
Fails to pass • 33%
No vote held • 33%
Contempt charges approved • 33%
Contempt charges denied • 33%
Contempt charges deferred • 34%
Passed by large majority • 33%
Passed by narrow margin • 34%
Rejected • 33%
Held in contempt • 33%
Not held in contempt • 33%
Vote postponed • 34%
Passes with majority • 33%
Fails to pass • 33%
No vote held • 33%
Passed by large margin • 33%
Passed by narrow margin • 33%
Rejected • 34%